Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
November 02, 2016Joseph R. Mikhael, MD, MEd, FRCPC, FACP: What is the best induction for transplant-eligible patients?Webcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies19 minPlay
November 02, 2016Jeremy S. Abramson, MD, MSc: Novel agents in follicular lymphomaWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies16 minPlay
November 02, 2016Tomer M. Mark, MD, MSc: Monoclonal antibodies: A new wave for the futureWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies22 minPlay
November 02, 2016Paul G. Richardson, MD: Relapsed myeloma: How to make sense of the many options availableWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies21 minPlay
November 02, 2016Jennifer R. Brown, MD, PhD: The BCR signaling pathwayWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies23 minPlay
November 02, 2016Y. Lynn Wang, MD, PhD, FCAP: Ibrutinib resistance-mechanisms and optionsWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies30 minPlay
November 02, 2016Susan Slager, PhD: The epidemiology of CLL: What do we know about risk?Webcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies25 minPlay
November 02, 2016Bruce D. Cheson, MD: Role of chemotherapy in CLL managementWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies23 minPlay
November 02, 2016Richard R. Furman, MD: Highlight of FDA approvals 2016: VenetoclaxWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies25 minPlay
November 02, 2016Steven Coutre, MD: Update on approved TKIs and their use in clinical practiceWebcast: Lymphoma and Myeloma 2016: An International Congress on Hematologic Malignanacies21 minPlay